RxDoctor Payments Data

Charles Horsley, MD

Family Medicine · Lebanon, OHNPI 1477546976

Payments from drug & device makers

$6,130in general payments, 2019–2025

Across 419 payments — averaging $14.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$683
  • AstraZeneca$647
  • AbbVie$594
  • Lilly USA, LLC$543
  • Novo Nordisk$471
  • Amgen$402
  • plus $3K from 36 others

What the payments were for

  • Food & beverage$6,118100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,130 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$125,666
Medicare patients
354
Services billed
2,682

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide95$159,412
JardianceEmpagliflozin78$102,025
EliquisApixaban78$82,354
JanuviaSitagliptin Phosphate62$74,670
Soliqua 100-33Insulin Glargine/Lixisenatide47$67,248
FarxigaDapagliflozin Propanediol56$63,058
Trelegy ElliptaFluticasone/Umeclidin/Vilanter51$52,304
XareltoRivaroxaban38$49,962
MounjaroTirzepatide26$46,073
Invega SustennaPaliperidone Palmitate12$43,994
XifaxanRifaximin13$40,854
TrulicityDulaglutide19$39,456
Tresiba Flextouch U-200Insulin Degludec26$38,117
Humalog Kwikpen U-200Insulin Lispro18$26,420
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog20$21,848

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$471$159,41295 claims
Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat$115$129,553108 claims
Johnson & JohnsonXarelto, Invega Sustenna$241$93,95650 claims
Lilly USA, LLCMounjaro, Trulicity$543$85,52945 claims
PfizerEliquis$683$82,35478 claims
MerckJanuvia$71$74,67062 claims
AstraZenecaFarxiga, Breztri Aerosphere$647$72,58271 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$196$67,24847 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$227$65,21274 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$53$40,85413 claims
AbbVieLinzess$594$17,42912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Lebanon

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →